Epidemiology of Intracranial Metastases in Korea: A National Cohort Investigation
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose To investigate the epidemiologic features of intracranial metastases (ICMET) in Korea, we performed a cohort study using the National Health Insurance Service–National Sample Cohort database, which comprised healthcare usage information of approximately 1 million Korean individuals over 12 years. Materials and Methods We enrolled 998,602 subjects, after excluding 18,218 subjects diagnosed with any cancer during the washout period (2002-2004). The observation period was 9 years (2005-2013; 8,725,438 person-years). The initial diagnosis date of ICMET and the primary cancer was recorded. The incidence was determined based on the number of incident cases and observation size, whereas survival was estimated using death statistics from the database. Results Through observation period, a total 776 subjects developed ICMET. The age-standardized incidence of ICMET was 8.2 per 100,000 person-years. The mean interval between the initial diagnosis date of the primary cancer and ICMET was 13.1 months. Patients with ICMET had shorter survival than those without ICMET (30.9 months vs. 81.4 months, p < 0.001). The ICMET incidence among the cancer patients was 5.0 per 1,000 personyears; it was highest in lung cancer cases, followed by breast and liver cancer cases. Moreover, ICMET from lung cancer was the most common metastasis type, followed by ICMET from liver and breast cancer. Conclusion The incidence of ICMET was 8.2 per 100,000 person-years among the Korean population and 5.0 per 1,000 person-years among cancer patients. Most of the ICMET cases arose from lung cancer. ICMET also critically influenced survival in cancer patients.
Abstract
Purpose To investigate the epidemiologic features of intracranial metastases (ICMET) in Korea, we performed a cohort study using the National Health Insurance Service–National Sample Cohort database, which comprised healthcare usage information of approximately 1 million Korean individuals over 12 years. Materials and Methods We enrolled 998,602 subjects, after excluding 18,218 subjects diagnosed with any cancer during the washout period (2002-2004). The observation period was 9 years (2005-2013; 8,725,438 person-years). The initial diagnosis date of ICMET and the primary cancer was recorded. The incidence was determined based on the number of incident cases and observation size, whereas survival was estimated using death statistics from the database. Results Through observation period, a total 776 subjects developed ICMET. The age-standardized incidence of ICMET was 8.2 per 100,000 person-years. The mean interval between the initial diagnosis date of the primary cancer and ICMET was 13.1 months. Patients with ICMET had shorter survival than those without ICMET (30.9 months vs. 81.4 months, p < 0.001). The ICMET incidence among the cancer patients was 5.0 per 1,000 personyears; it was highest in lung cancer cases, followed by breast and liver cancer cases. Moreover, ICMET from lung cancer was the most common metastasis type, followed by ICMET from liver and breast cancer. Conclusion The incidence of ICMET was 8.2 per 100,000 person-years among the Korean population and 5.0 per 1,000 person-years among cancer patients. Most of the ICMET cases arose from lung cancer. ICMET also critically influenced survival in cancer patients.
참고문헌 (18)
- Nayak L, "Epidemiology of brain metastases", Curr Oncol Rep, 14, pp.48~54 (2012)[DOI]
- Barker FG 2nd, "Craniotomy for the resection of metastatic brain tumors in the U.S., 1988-2000: decreasing mortality and the effect of provider caseload", Cancer, 100, pp.999~1007 (2004)[DOI]
- Barnholtz-Sloan JS, "Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System", J Clin Oncol, 22, pp.2865~2872 (2004)[DOI]
- Counsell CE, "Incidence of intracranial tumours in the Lothian region of Scotland, 1989-90", J Neurol Neurosurg Psychiatry, 61, pp.143~150 (1996)[DOI]
- Materljan E, "Epidemiology of central nervous system tumors in Labin area, Croatia, 1974-2001", Croat Med J, 45, pp.206~212 (2004)
- Schouten LJ, "Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma", Cancer, 94, pp.2698~2705 (2002)[DOI]
- Smedby KE, "Brain metastases admissions in Sweden between 1987 and 2006", Br J Cancer, 101, pp.1919~1924 (2009)[DOI]
- 오창모, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013", Cancer Research and Treatment, 48(2), pp.436~450 (2016), 대한암학회
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2016", Cancer Research and Treatment, 48(2), pp.451~457 (2016), 대한암학회
- Lee J, "Cohort profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)
- Rothman KJ, "Modern epidemiology. 2nd ed." (1998), Lippincott Williams & Wilkins
- Ahmad OB, "Age standardization of rates: a new WHO standard", ~ (2001)
- Scheaffer RL, "Elementary survey sampling" (2011), Cengage Learning
- Tabouret E, "Recent trends in epidemiology of brain metastases: an overview", Anticancer Res, 32, pp.4655~4662 (2012)
- Kim M, "Nervous system involvement by metastatic hepatocellular carcinoma", J Neurooncol, 36, pp.85~90 (1998)[DOI]
- Shao YY, "Increasing incidence of brain metastasis in patients with advanced hepatocellular carcinoma in the era of antiangiogenic targeted therapy", Oncologist, 16, pp.82~86 (2011)[DOI]
- Murakami K, "Intracranial metastases of hepatocellular carcinoma: CT and MRI", Neuroradiology, 38(Suppl 1), pp.S31~S35 (1996)[DOI]
- Park Y, "Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with whole-brain radiotherapy: a multicenter retrospective study", J Neurooncol, 125, pp.377~383 (2015)[DOI]